MED-EL Medical Electronics

MED-EL Medical Electronics is an Austrian medical technology company developing implantable hearing systems, audio processors and neuroprosthetic technologies. Based in Innsbruck, it combines research, engineering and manufacturing with clinical support and rehabilitation resources for people with hearing loss. Its portfolio addresses sensorineural, conductive and mixed hearing loss through several complementary approaches.

Hearing technology and rehabilitation

The company develops cochlear implants, electric acoustic stimulation systems, active middle ear implants, bone conduction solutions and auditory brainstem implants. Its hearing systems include implanted components alongside behind-the-ear and single-unit audio processors. Non-surgical bone conduction devices provide an additional approach within its broader hearing technology portfolio.

Alongside these devices, MED-EL develops fitting software, digital hearing assessment tools, remote patient management systems and interactive auditory rehabilitation platforms. These technologies support assessment, device management and speech and listening practice. Its work also extends into functional electrical stimulation and neurorehabilitation through the STIWELL product division.

MED-EL provides clinical, surgical and audiological training for healthcare professionals, together with technical servicing, maintenance and processor upgrade programmes. Patient resources include rehabilitation tools and community support platforms. This combination connects device development with the practical work of fitting, supporting and maintaining hearing systems over time.

Scientific origins and international development

The company's scientific roots extend to cochlear implant research conducted by Ingeborg and Erwin Hochmair during the 1970s. Their work established the technological foundation for the business founded in Innsbruck in 1989. MED-EL hired its first employees in 1990 and introduced a behind-the-ear cochlear implant audio processor in 1991.

The business remains privately held and family-run, with research, development and manufacturing centred in Austria. An international network of subsidiaries and clinical support structures serves hearing implant recipients across more than 140 countries. Its development has expanded from early cochlear implant research into a broader portfolio combining implantable devices, external processors, digital health tools and rehabilitation technology.